APA citiranje

Chifotides, H. T., Masarova, L., Alfayez, M., Daver, N., Alvarado, Y., Jabbour, E., . . . Verstovsek, S. (2020). Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors. Blood Adv.

Citação norma Chicago

Chifotides, Helen T., et al. "Outcome of Patients With IDH1/2-mutated Post–myeloproliferative Neoplasm AML in the Era of IDH Inhibitors." Blood Adv 2020.

MLA citiranje

Chifotides, Helen T., et al. "Outcome of Patients With IDH1/2-mutated Post–myeloproliferative Neoplasm AML in the Era of IDH Inhibitors." Blood Adv 2020.